Global clinical reach Rimed’s TCD solutions are installed in over 100 countries with more than 10,000 installations across neurology, stroke, neurosurgery, ICU, and NICU settings, indicating strong cross-specialty appeal and durable demand in hospital departments.

Comprehensive approvals All products carry FDA, CE and NMPA (CFDA) approvals and ISO 13485 certification, supporting easier market access and faster procurement cycles in regulated markets.

Expansion opportunities Upcoming conference participation in Brazil and the Philippines signals active regional growth; leverage these events to secure sponsor, demo, and speaking opportunities to drive pipeline in expanding healthcare markets.

Product differentiation Innovations such as Auto-Track automatic signal tracking and imaging modules for carotid and intracranial arteries position Rimed to upsell advanced features and cross-sell to centers investing in comprehensive neurovascular ultrasound capabilities.

SME friendly size With 11-50 employees and revenue in the $25M–$50M range, Rimed presents a nimble decision-making profile, enabling targeted outreach to procurement leaders in mid-sized hospitals and regional health systems seeking reliable, proven TCD solutions.